{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T00:08:00Z","timestamp":1783642080661,"version":"3.55.0"},"reference-count":46,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2016,3,1]],"date-time":"2016-03-01T00:00:00Z","timestamp":1456790400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,3,1]],"date-time":"2016-03-01T00:00:00Z","timestamp":1456790400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"name":"Welton Foundation"},{"name":"NIHR Respiratory Disease Biomedical Research Unit"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","journalofinfection.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Infection"],"published-print":{"date-parts":[[2016,3]]},"DOI":"10.1016\/j.jinf.2015.12.007","type":"journal-article","created":{"date-parts":[[2015,12,24]],"date-time":"2015-12-24T01:45:20Z","timestamp":1450921520000},"page":"324-331","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":118,"title":["The antimicrobial susceptibility of non-tuberculous mycobacteria"],"prefix":"10.1016","volume":"72","author":[{"given":"S.","family":"Cowman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.","family":"Burns","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Benson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Wilson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.R.","family":"Loebinger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jinf.2015.12.007_bib1","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1055\/s-0033-1333568","article-title":"Ecology of nontuberculous mycobacteria-where do human infections come from?","volume":"34","author":"Falkinham","year":"2013","journal-title":"Semin Respir Crit Care Med"},{"key":"10.1016\/j.jinf.2015.12.007_bib2","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1056\/NEJM198909283211304","article-title":"Infection with Mycobacterium avium complex in patients without predisposing conditions","volume":"321","author":"Prince","year":"1989","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jinf.2015.12.007_bib3","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1164\/rccm.201111-2016OC","article-title":"Prevalence of nontuberculous mycobacterial lung disease in U.S. medicare beneficiaries","volume":"185","author":"Adjemian","year":"2012","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jinf.2015.12.007_bib4","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1186\/1471-2458-10-612","article-title":"Increasing reports of non-tuberculous mycobacteria in England, Wales and Northern Ireland, 1995\u20132006","volume":"10","author":"Moore","year":"2010","journal-title":"BMC Public Health"},{"key":"10.1016\/j.jinf.2015.12.007_bib5","first-page":"1186","article-title":"Non-tuberculous mycobacteria: patterns of isolation. A multi-country retrospective survey","volume":"8","author":"Mart\u00edn-Casabona","year":"2004","journal-title":"Int J Tuberc Lung Dis"},{"key":"10.1016\/j.jinf.2015.12.007_bib6","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1164\/rccm.200604-571ST","article-title":"An official ATS\/IDSA statement: diagnosis, treatment, and prevention of nontuberculous mycobacterial diseases","volume":"175","author":"Griffith","year":"2007","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jinf.2015.12.007_bib7","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1136\/thorax.56.3.167","article-title":"First randomised trial of treatments for pulmonary disease caused by M avium intracellulare, M malmoense, and M xenopi in HIV negative patients: rifampicin, ethambutol and isoniazid versus rifampicin and ethambutol","volume":"56","year":"2001","journal-title":"Thorax"},{"key":"10.1016\/j.jinf.2015.12.007_bib8","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.2217\/fmb.14.60","article-title":"Drug susceptibility testing of nontuberculous mycobacteria","volume":"9","author":"van Ingen","year":"2014","journal-title":"Future Microbiol"},{"key":"10.1016\/j.jinf.2015.12.007_bib9","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1164\/ajrccm.160.3.9811086","article-title":"Effect of clarithromycin regimen for Mycobacterium avium complex pulmonary disease","volume":"160","author":"Tanaka","year":"1999","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jinf.2015.12.007_bib10","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1007\/s10156-006-0457-8","article-title":"Relationship between clinical efficacy of treatment of pulmonary Mycobacterium avium complex disease and drug-sensitivity testing of Mycobacterium avium complex isolates","volume":"12","author":"Kobashi","year":"2006","journal-title":"J Infect Chemother Off J Japan Soc Chemother"},{"key":"10.1016\/j.jinf.2015.12.007_bib11","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1164\/rccm.200603-450OC","article-title":"Clinical and molecular analysis of macrolide resistance in Mycobacterium avium complex lung disease","volume":"174","author":"Griffith","year":"2006","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jinf.2015.12.007_bib12","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1159\/000095674","article-title":"The microbiological and clinical effects of combined therapy according to guidelines on the treatment of pulmonary Mycobacterium avium complex disease in Japan \u2013 including a follow-up study","volume":"74","author":"Kobashi","year":"2007","journal-title":"Respiration"},{"key":"10.1016\/j.jinf.2015.12.007_bib13","series-title":"R: a language and environment for statistical computing","author":"R Core Team","year":"2014"},{"key":"10.1016\/j.jinf.2015.12.007_bib14","series-title":"ggplot2: elegant graphics for data analysis","author":"Wickham","year":"2009"},{"key":"10.1016\/j.jinf.2015.12.007_bib15","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1136\/thoraxjnl-2013-204260","article-title":"Non-tuberculous mycobacteria: a retrospective review of Scottish isolates from 2000 to 2010","volume":"69","author":"Russell","year":"2014","journal-title":"Thorax"},{"key":"10.1016\/j.jinf.2015.12.007_bib16","doi-asserted-by":"crossref","first-page":"e795","DOI":"10.1016\/j.ijid.2011.07.004","article-title":"Isolation of multiple nontuberculous mycobacteria species in the same patients","volume":"15","author":"Lim","year":"2011","journal-title":"Int J Infect Dis"},{"key":"10.1016\/j.jinf.2015.12.007_bib17","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/S0041-3879(68)80004-2","article-title":"Disseminated infection with Mycobacterium avium: II. Bacteriology and drug susceptibility","volume":"49","author":"Clark","year":"1968","journal-title":"Tubercle"},{"key":"10.1016\/j.jinf.2015.12.007_bib18","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1128\/AAC.2.4.245","article-title":"Susceptibility of mycobacteria to rifampin","volume":"2","author":"Woodley","year":"1972","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jinf.2015.12.007_bib19","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1378\/chest.75.2.115","article-title":"Pulmonary mycobacterial infections due to Mycobacterium intracellulare-avium complex. Clinical features and course in 100 consecutive cases","volume":"75","author":"Rosenzweig","year":"1979","journal-title":"Chest"},{"key":"10.1016\/j.jinf.2015.12.007_bib20","first-page":"442","article-title":"Medical therapy of Mycobacterium avium-intracellulare pulmonary disease","volume":"134","author":"Etzkorn","year":"1986","journal-title":"Am Rev Respir Dis"},{"key":"10.1016\/j.jinf.2015.12.007_bib21","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1093\/clinids\/3.5.1035","article-title":"Treatment of pulmonary disease due to Mycobacterium kansasii: recent experience with rifampin","volume":"3","author":"Pezzia","year":"1981","journal-title":"Rev Infect Dis"},{"key":"10.1016\/j.jinf.2015.12.007_bib22","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1093\/clinids\/18.5.736","article-title":"Rifampin-resistant Mycobacterium kansasii","volume":"18","author":"Richard","year":"1994","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jinf.2015.12.007_bib23","doi-asserted-by":"crossref","first-page":"905","DOI":"10.7326\/0003-4819-121-12-199412150-00001","article-title":"Clarithromycin therapy for bacteremic Mycobacterium avium complex disease. A randomized, double-blind, dose-ranging study in patients with AIDS. AIDS Clinical Trials Group Protocol 157 Study Team","volume":"121","author":"Chaisson","year":"1994","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jinf.2015.12.007_bib24","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1378\/chest.107.4.1035","article-title":"Clarithromycin in the treatment of Mycobacterium avium lung infections in patients without AIDS","volume":"107","author":"Dautzenberg","year":"1995","journal-title":"Chest"},{"key":"10.1016\/j.jinf.2015.12.007_bib25","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1164\/ajrccm.149.5.8173775","article-title":"Initial clarithromycin monotherapy for Mycobacterium avium-intracellulare complex lung disease","volume":"149","author":"Wallace","year":"1994","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jinf.2015.12.007_bib26","doi-asserted-by":"crossref","first-page":"1766","DOI":"10.1164\/ajrccm.153.6.8665032","article-title":"Clarithromycin regimens for pulmonary Mycobacterium avium complex. The first 50 patients","volume":"153","author":"Wallace","year":"1996","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jinf.2015.12.007_bib27","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1164\/rccm.200905-0704OC","article-title":"Antibiotic treatment of Mycobacterium abscessus lung disease: a retrospective analysis of 65 patients","volume":"180","author":"Jeon","year":"2009","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jinf.2015.12.007_bib28","doi-asserted-by":"crossref","first-page":"3389","DOI":"10.1128\/JCM.01612-13","article-title":"In\u00a0vitro activity of amikacin against isolates of Mycobacterium avium complex with proposed MIC breakpoints and finding of a 16S rRNA gene mutation in treated isolates","volume":"51","author":"Brown-Elliott","year":"2013","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.jinf.2015.12.007_bib29","series-title":"Susceptibility testing of mycobacteria, Nocardiae, and other aerobic actinomycetes (CLSI document M24-A2)","author":"Clinical Laboratory Standards Institute","year":"2011"},{"key":"10.1016\/j.jinf.2015.12.007_bib30","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1128\/JCM.02260-12","article-title":"Comparative drug resistance of Mycobacterium abscessus and M. chelonae isolates from patients with and without cystic fibrosis in the United Kingdom","volume":"51","author":"Broda","year":"2013","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.jinf.2015.12.007_bib31","doi-asserted-by":"crossref","first-page":"1987","DOI":"10.1128\/AAC.36.9.1987","article-title":"Activities of clarithromycin against eight slowly growing species of nontuberculous mycobacteria, determined by using a broth microdilution MIC system","volume":"36","author":"Brown","year":"1992","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jinf.2015.12.007_bib32","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1099\/jmm.0.45965-0","article-title":"Mycobacterium kansasii: antibiotic susceptibility and PCR-restriction analysis of clinical isolates","volume":"54","author":"da Silva Telles","year":"2005","journal-title":"J Med Microbiol"},{"key":"10.1016\/j.jinf.2015.12.007_bib33","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1093\/jac\/dki111","article-title":"In\u00a0vitro activity of linezolid, clarithromycin and moxifloxacin against clinical isolates of Mycobacterium kansasii","volume":"55","author":"Guna","year":"2005","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.jinf.2015.12.007_bib34","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1016\/S0924-8579(03)00048-7","article-title":"In\u00a0vitro activity of new fluoroquinolones and linezolid against non-tuberculous mycobacteria","volume":"21","author":"Rodriguez D\u00edaz","year":"2003","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.jinf.2015.12.007_bib35","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1128\/AAC.28.6.807","article-title":"Antimicrobial susceptibility of five subgroups of Mycobacterium fortuitum and Mycobacterium chelonae","volume":"28","author":"Swenson","year":"1985","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jinf.2015.12.007_bib36","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1128\/jcm.24.6.976-981.1986","article-title":"Susceptibility testing of slowly growing mycobacteria by a microdilution MIC method with 7H9 broth","volume":"24","author":"Wallace","year":"1986","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.jinf.2015.12.007_bib37","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/S1684-1182(10)60063-1","article-title":"Clinical outcome of Mycobacterium abscessus infection and antimicrobial susceptibility testing","volume":"43","author":"Huang","year":"2010","journal-title":"J Microbiol Immunol Infect"},{"key":"10.1016\/j.jinf.2015.12.007_bib38","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1186\/1471-2334-13-493","article-title":"Identification of non-tuberculous mycobacteria isolated from clinical specimens at a tertiary care hospital: a cross-sectional study","volume":"13","author":"Ahmed","year":"2013","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.jinf.2015.12.007_bib39","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.ijantimicag.2009.09.023","article-title":"In\u00a0vitro drug susceptibility of 2275 clinical non-tuberculous Mycobacterium isolates of 49 species in The Netherlands","volume":"35","author":"van Ingen","year":"2010","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.jinf.2015.12.007_bib40","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/j.ijmm.2013.04.003","article-title":"Drug susceptibility distributions in slowly growing non-tuberculous mycobacteria using MGIT 960 TB eXiST","volume":"303","author":"Hombach","year":"2013","journal-title":"Int J Med Microbiol"},{"key":"10.1016\/j.jinf.2015.12.007_bib41","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1093\/jac\/dkr399","article-title":"Automated quantitative drug susceptibility testing of non-tuberculous mycobacteria using MGIT 960\/EpiCenter TB eXiST","volume":"67","author":"Lucke","year":"2012","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.jinf.2015.12.007_bib42","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1136\/thx.2007.087999","article-title":"Clarithromycin vs ciprofloxacin as adjuncts to rifampicin and ethambutol in treating opportunist mycobacterial lung diseases and an assessment of Mycobacterium vaccae immunotherapy","volume":"63","author":"Jenkins","year":"2008","journal-title":"Thorax"},{"key":"10.1016\/j.jinf.2015.12.007_bib43","doi-asserted-by":"crossref","first-page":"1482","DOI":"10.1378\/chest.124.4.1482","article-title":"Treatment of Mycobacterium avium-intracellulare complex lung disease with a macrolide, ethambutol, and clofazimine","volume":"124","author":"Field","year":"2003","journal-title":"Chest"},{"key":"10.1016\/j.jinf.2015.12.007_bib44","doi-asserted-by":"crossref","first-page":"6324","DOI":"10.1128\/AAC.01505-12","article-title":"In\u00a0vitro synergy between clofazimine and amikacin in treatment of nontuberculous mycobacterial disease","volume":"56","author":"van Ingen","year":"2012","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jinf.2015.12.007_bib45","doi-asserted-by":"crossref","first-page":"1945","DOI":"10.1093\/jac\/dku062","article-title":"Clinical experience in 52 patients with tigecycline-containing regimens for salvage treatment of Mycobacterium abscessus and Mycobacterium chelonae infections","volume":"69","author":"Wallace","year":"2014","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.jinf.2015.12.007_bib46","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1128\/AAC.45.3.764-767.2001","article-title":"Activities of linezolid against rapidly growing mycobacteria","volume":"45","author":"Wallace","year":"2001","journal-title":"Antimicrob Agents Chemother"}],"container-title":["Journal of Infection"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0163445315003977?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0163445315003977?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T21:22:44Z","timestamp":1759008164000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0163445315003977"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,3]]},"references-count":46,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2016,3]]}},"alternative-id":["S0163445315003977"],"URL":"https:\/\/doi.org\/10.1016\/j.jinf.2015.12.007","relation":{},"ISSN":["0163-4453"],"issn-type":[{"value":"0163-4453","type":"print"}],"subject":[],"published":{"date-parts":[[2016,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The antimicrobial susceptibility of non-tuberculous mycobacteria","name":"articletitle","label":"Article Title"},{"value":"Journal of Infection","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jinf.2015.12.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 The British Infection Association. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}